CBS 2019
CBSMD教育中心
中 文

Transcatheter Aortic Valve Replacement

Abstract

Recommended Article

2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) Comparison of 1-Year Pre- And Post-Transcatheter Aortic Valve Replacement Hospitalization Rates: A Population-Based Cohort Study Bioprosthetic valve oversizing is associated with increased risk of valve thrombosis following TAVR Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial Extracellular Myocardial Volume in Patients With Aortic Stenosis Relationship between B-type natriuretic peptide and invasive haemodynamics in patients with severe aortic valve stenosis Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI

GuidelineVolume 36, Issue 44, 21 November 2015

JOURNAL:Eur Heart J. Article Link

2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)

G Habib, P Lancellotti, MJ Antunes et al. Keywords: infective endocarditis

Full Text PDF